Powered by: Motilal Oswal
2025-08-13 02:17:55 pm | Source: Accord Fintech
Daikaffil Chemicals India zooms on getting nod to incorporate wholly owned subsidiary companies in Nigeria, UAE
Daikaffil Chemicals India zooms on getting nod to incorporate wholly owned subsidiary companies in Nigeria, UAE

Daikaffil Chemicals India is currently trading at Rs 144.00, up by 11.40 points or 8.60% from its previous closing of Rs 132.60 on the BSE.

The scrip opened at Rs 132.95 and has touched a high and low of Rs 144.70 and Rs 131.45 respectively. So far 3224 shares were traded on the counter.

The BSE group 'X' stock of face value Rs 10 has touched a 52-week high of Rs 281.00 on 08-Jan-2025 and a 52-week low of Rs 124.65 on 29-Jul-2025.

Last one week high and low of the scrip stood at Rs 144.70 and Rs 126.20 respectively. The current market cap of the company is Rs 86.82 crore.

The promoters holding in the company stood at 52.65%, while non-institutions held 47.35%.

Daikaffil Chemicals India has received approval for incorporation of a Wholly Owned Subsidiary (WOS) companies in Nigeria and United Arab Emirates (UAE). Subsidiaries to be incorporated will be carrying the business of Chemical Products i.e. Pesticides, Insecticides, Herbicides, Fungicides, Weedicides etc. The company is proposing to make an initial investment of upto Rs 2.00 crore in the proposed Wholly Owned Subsidiaries.

The Board of the Directors of the Company at their meeting held on August 12, 2025, has approved the same.

Daikaffil Chemicals India is engaged in manufacturing of organic chemicals and intermediaries and trading of chemicals.

 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here